Lung cancer: active therapeutic targeting and inhalational nanoproduct design

Nasser Alhajj, Chin Fei Chee, Tin Wui Wong, Noorsaadah Abd Rahman, Noor Hayaty Abu Kasim, Paolo Colombo

Research output: Contribution to journalReview articlepeer-review

13 Citations (Scopus)


Introduction: Pulmonary drug delivery is organ-specific and benefits local drug action for lung cancer. The use of nanotechnology and targeting ligand enables cellular-specific drug action. Combination approaches increase therapeutic efficacy and reduce adverse effects of cancer chemotherapeutics that have narrow therapeutic index window and high cytotoxicity levels. The current progress of inhaled cancer chemotherapeutics has not been examined with respect to targeting strategy and clinical application potential. Areas covered: This review examines the state of the art in passive (processing and formulation) and active (targeting ligand and receptor binding) technologies in association with the use of nanocarrier to combat lung cancer. It highlights routes to equip nanocarrier with targeting ligands as a function of the chemistry of participating biomolecules and challenges in inhalational nanoproduct development and clinical applications. Both research and review articles were examined using the Scopus, Elsevier, Web of Science, Chemical Abstracts, Medline, CASREACT, CHEMCATS, and CHEMLIST database with the majority of information retrieved between those of 2000–2018. Expert commentary: The therapeutic efficacy of targeting ligand-decorated nanocarriers needs to be demonstrated in vivo in the form of finished inhalational products. Their inhalation efficiency and medical responses require further examination. Clinical application of inhaled nanocancer chemotherapeutics is premature.

Original languageEnglish
Pages (from-to)1223-1247
Number of pages25
JournalExpert Opinion on Drug Delivery
Issue number12
Publication statusPublished - 02 Dec 2018
Externally publishedYes


  • Cancer
  • inhalation
  • lung
  • nanocarrier
  • targeting ligand


Dive into the research topics of 'Lung cancer: active therapeutic targeting and inhalational nanoproduct design'. Together they form a unique fingerprint.

Cite this